Keep up to date with news from Gamma Gurus — Featured

After a well deserved maternity leave, we're so elated to have Nicole Pritchard back on board that we also gave her a promotion!  Nicole is now our Head Radiotherapy Product Guru and will be focussing on key accounts as well as continuing to manage sales of our clinical radiotherapy protfolio. Joining Nicole is Louis Shu who is also a trained Radiation Therapist and has joined us from the Peter MacCallum Cancer Centre.  Louis will be taking over some of Nicole's day-to-day customer interactions and will ensure our high level of customer service is maintained as our product range continues to grow.

Gamma Gurus is proudly B-Corp certified. Certified B Corporations are leaders in the global movement for an inclusive, equitable, and regenerative economy. Unlike our other certifications, such as ISO9001 and ISO 17025, this uniquely measures a company’s entire social and environmental impact.

Gamma Gurus is very pleased to announce the signing of an agency agreement with Bruker BioSpin to market their portfolio of Nuclear Molecular Imaging (NMI) products in Australia & New Zealand. This expands our ability to support the preclinical NMI field by adding additional products, including PET/MR, to the already successful Molecubes range that was acquired by Bruker in November 2021. We look forward to introducing these new products to our customers in 2023!

RadTat is the first non-invasive, semi-permanent skin marking for radiation oncology and Gamma Gurus is pleased to be able to offer this innovative product in Australia. RadTats were designed with both patients and providers in mind as a simple and painless alternative to permanent tatoos that will last for up to two weeks with little to no maintenance by patient or care provider. This is not a sticker! RadTat provides a quick, simple solution that lasts! RadTat Semi-permanent Skin Marking – Gamma Gurus

The University of Queensland Centre for Advanced Imaging is the first centre in Australia to install a Molecubes SPECT and CT combination Y-CUBE and X-CUBE. These high-performance imaging systems will allow the CAI to remain at the forefront of preclinical SPECT/CT research and they even do so with a nice view of the cricket grounds!